BioLineRx Ltd. (BLRX.TA)
ILA 1.7
(0.0%)
ILA 1.7
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 USD | -134.7% |
| 2022 | -0.03 USD | 36.94% |
| 2021 | -0.04 USD | 64.58% |
| 2020 | -0.12 USD | 33.33% |
| 2019 | -0.18 USD | 14.29% |
| 2018 | -0.21 USD | 22.22% |
| 2017 | -0.27 USD | 3.57% |
| 2016 | -0.28 USD | 0.0% |
| 2015 | -0.28 USD | 9.68% |
| 2014 | -0.31 USD | 60.26% |
| 2013 | -0.78 USD | 35.54% |
| 2012 | -1.21 USD | -13.08% |
| 2011 | -1.07 USD | -729.41% |
| 2010 | 0.17 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.00 USD | 166.67% |
| 2024 Q1 | -0.00 USD | 95.35% |
| 2023 Q4 | -0.01 USD | 25.0% |
| 2023 Q2 | -0.02 USD | -19.64% |
| 2023 FY | - USD | -134.7% |
| 2023 Q3 | -0.02 USD | 14.43% |
| 2023 Q1 | -0.02 USD | -320.0% |
| 2022 Q2 | -0.01 USD | -92.45% |
| 2022 Q3 | -0.01 USD | 12.75% |
| 2022 Q4 | -0.00 USD | 55.06% |
| 2022 FY | - USD | 36.94% |
| 2022 Q1 | -0.01 USD | 18.46% |
| 2021 Q1 | -0.02 USD | 61.6% |
| 2021 Q2 | -0.01 USD | 43.96% |
| 2021 Q4 | -0.01 USD | 19.75% |
| 2021 FY | - USD | 64.58% |
| 2021 Q3 | -0.01 USD | 20.59% |
| 2020 Q2 | -0.03 USD | 18.57% |
| 2020 Q4 | -0.05 USD | -203.85% |
| 2020 FY | - USD | 33.33% |
| 2020 Q3 | -0.02 USD | 49.19% |
| 2020 Q1 | -0.04 USD | 44.07% |
| 2019 Q2 | -0.04 USD | 18.57% |
| 2019 Q1 | -0.05 USD | 10.96% |
| 2019 FY | - USD | 14.29% |
| 2019 Q3 | -0.03 USD | 29.97% |
| 2019 Q4 | -0.07 USD | -155.3% |
| 2018 Q2 | -0.04 USD | 23.12% |
| 2018 FY | - USD | 22.22% |
| 2018 Q4 | -0.05 USD | 11.86% |
| 2018 Q3 | -0.06 USD | -31.4% |
| 2018 Q1 | -0.06 USD | 28.61% |
| 2017 Q2 | -0.05 USD | 37.44% |
| 2017 Q1 | -0.08 USD | -8.52% |
| 2017 FY | - USD | 3.57% |
| 2017 Q4 | -0.08 USD | -15.05% |
| 2017 Q3 | -0.07 USD | -37.26% |
| 2016 Q3 | -0.08 USD | -16.01% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | -0.06 USD | 10.42% |
| 2016 Q2 | -0.07 USD | -4.09% |
| 2016 Q4 | -0.08 USD | 0.65% |
| 2015 FY | - USD | 9.68% |
| 2015 Q4 | -0.07 USD | -138.26% |
| 2015 Q3 | -0.03 USD | 66.82% |
| 2015 Q2 | -0.09 USD | 10.2% |
| 2015 Q1 | -0.10 USD | 9.09% |
| 2014 Q3 | -0.02 USD | 83.42% |
| 2014 Q2 | -0.12 USD | -52.87% |
| 2014 FY | - USD | 60.26% |
| 2014 Q1 | -0.08 USD | 62.62% |
| 2014 Q4 | -0.11 USD | -452.76% |
| 2013 Q2 | -0.19 USD | -18.75% |
| 2013 Q1 | -0.16 USD | 62.79% |
| 2013 Q4 | -0.21 USD | 0.0% |
| 2013 FY | - USD | 35.54% |
| 2013 Q3 | -0.21 USD | -10.53% |
| 2012 FY | - USD | -13.08% |
| 2012 Q3 | -0.33 USD | -120.0% |
| 2012 Q2 | -0.15 USD | 53.13% |
| 2012 Q1 | -0.32 USD | -10.34% |
| 2012 Q4 | -0.43 USD | -30.3% |
| 2011 Q1 | -0.26 USD | 45.83% |
| 2011 Q3 | -0.16 USD | 60.98% |
| 2011 Q4 | -0.29 USD | -81.25% |
| 2011 FY | - USD | -729.41% |
| 2011 Q2 | -0.41 USD | -57.69% |
| 2010 Q1 | -0.34 USD | 0.0% |
| 2010 Q2 | -0.36 USD | -5.88% |
| 2010 Q3 | 1.61 USD | 547.22% |
| 2010 Q4 | -0.48 USD | -129.81% |
| 2010 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Matricelf Ltd | -0.95 ILA | 93.379% |